KRAS mutant colorectal cancer gene signatures identified angiotensin II receptor blockers as potential therapies. - Wikidata - awgldk - TriplyDB

KRAS mutant colorectal cancer gene signatures identified angiotensin II receptor blockers as potential therapies.

KRAS mutant colorectal cancer gene signatures identified angiotensin II receptor blockers as potential therapies.

http://www.wikidata.org/entity/Q37709450

about

LC-MS-based metabolomics revealed SLC25A22 as an essential regulator of aspartate-derived amino acids and polyamines in KRAS-mutant colorectal cancer.

P2860

Q47118348-7E959757-A824-444D-B89F-8C143CBFD255

P2860

KRAS mutant colorectal cancer gene signatures identified angiotensin II receptor blockers as potential therapies.

http://www.wikidata.org/entity/Q37709450

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 10 December 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

KRAS mutant colorectal cancer ...... ockers as potential therapies.

@en

KRAS mutant colorectal cancer ...... ockers as potential therapies.

@nl

type

label

KRAS mutant colorectal cancer ...... ockers as potential therapies.

@en

KRAS mutant colorectal cancer ...... ockers as potential therapies.

@nl

prefLabel

KRAS mutant colorectal cancer ...... ockers as potential therapies.

@en

KRAS mutant colorectal cancer ...... ockers as potential therapies.

@nl

P1433

Q37709450-98D5904C-4797-4F2B-B172-E1DA835C92D3

P1476

Q37709450-3CE83CC5-5DA3-4830-99AF-7D86394FD03E

P2093

Q37709450-45AE0B7E-306D-4F2B-A6BF-32CE45D4E250

Q37709450-585EBE76-F57F-44A8-A81E-58179FAFCD9A

Q37709450-6BB57267-BF94-4D5C-BCB1-961D30B8C886

Q37709450-6FE128CD-A3E0-4249-8CE0-BA4320FAFCD6

Q37709450-9EE02639-6F03-4326-93B2-B9CFB49F5091

P2860

Q37709450-0913038F-CAA9-4705-A8D8-0C8A4190286A

Q37709450-0E1ABC9D-D59C-4952-A2BA-1ACE50E5A3FE

Q37709450-108CC039-6428-42DA-904D-19F9DEA274E4

Q37709450-12A4241C-DCA2-4B34-AC8C-720BD5D51BA5

Q37709450-13BDF984-265F-4FF7-9CA3-19CF282E04FB

Q37709450-1743C606-38C9-4A07-B85D-6A99BB3EA75E

Q37709450-19290933-C769-4565-80F6-8FAAC30A1154

Q37709450-1D33C511-5A75-44AB-8782-25D6A55842B1

Q37709450-2B9939AD-4305-49BB-9EEB-1CABFD095003

Q37709450-30933F17-20E7-4159-8667-AE098B3B3B79

P304

Q37709450-25448D10-9B54-44BD-A74A-ADD43D0D097F

P31

Q37709450-98ADA8C6-2004-4A4B-B878-E0BCC848A60A

P356

Q37709450-D3938281-4943-42CD-A548-FDE00726BDBD

P407

Q37709450-C5BD8090-A228-44E7-9F07-AB382F61CEB0

P433

Q37709450-20F899EA-1444-4856-ABD8-3BC63FF91459

P478

Q37709450-F62F3A5A-DF77-404D-9BFC-588B85B1057C

P50

Q37709450-55D73F69-5398-4566-922A-2DA49F11AE7F

Q37709450-56C8CA53-5653-4119-9A0F-D82F9C0C14C7

Q37709450-C078E79A-A315-4A3A-BFD6-7DC36A7F902F

P577

Q37709450-87269B66-2541-4855-A016-0F9360A4C874

P698

Q37709450-4790546E-6F05-4B6F-97DD-C44A4C6F4DA2

P921

Q37709450-9BAB535E-43CC-45BC-9AAB-FFC04DBE010F

P932

Q37709450-C85D080E-E46C-4142-BCCA-71E956A61502

P356

ONCOTARGET.13884

P1433

P1476

KRAS mutant colorectal cancer ...... ockers as potential therapies.

@en

P2093

Anthony J Bjourson

http://www.w3.org/2001/XMLSchema#string

Gerald Li

http://www.w3.org/2001/XMLSchema#string

Paul G O'Reilly

http://www.w3.org/2001/XMLSchema#string

Peter W Hamilton

http://www.w3.org/2001/XMLSchema#string

Qing Wen

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

Hallmarks of Cancer: The Next Generation

Small molecule inhibition of the KRAS-PDEδ interaction impairs oncogenic KRAS signalling

KEGG: kyoto encyclopedia of genes and genomes

The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases

Wnt signal transduction pathways

World Hypertension Day and global awareness

RAF suppression synergizes with MEK inhibition in KRAS mutant cancer cells.

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value

P304

3206-3225

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.13884

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Darragh G McArt

P577

2016-12-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27965461

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

5356876

http://www.w3.org/2001/XMLSchema#string